Join the club for FREE to access the whole archive and other member benefits.

David Fox

Leading authority on the regulation of prescription and over-the-counter drugs, biological products and controlled substances

Mr. Fox currently serves as a Partner at Hogan Lovells, an American-British law firm that specializes in government regulatory, litigation, commercial litigation and arbitration, corporate, finance, and intellectual property. He advises management teams, from start-ups to the largest global pharmaceutical and biotechnology companies, on matters before the Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA).

Mr. Fox is closely integrated with funding sources for the industry and is frequently retained as a strategic advisor on assessing the value of life sciences assets. Known for his collaborative approach to complex regulatory issues, Mr. Fox has successfully resolved numerous disputes between sponsors and staff at FDA on products that raise novel regulatory issues. As a former senior lawyer for FDA and throughout his career in private practice, Mr. Fox has been deeply immersed in the regulatory side of the Hatch-Waxman Act, including pioneer-generic disputes and numerous cases of first impression involving exclusivity issues, Orange Book listings, and patent term extensions.

Visit website:


See also: Company Hogan Lovells - American-British law firm co-headquartered in London and Washington

Details last updated 19-Jun-2021

David Fox is also referenced in the following:

Metabesity 2021

11-Oct-2021 to 14-Oct-2021

The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan

Targeting Metabesity 2022

10-Oct-2022 to 13-Oct-2022

The Kitalys Institute virtual conference about going beyond treating individual diseases to extending healthy lifespan